Post by highskier on Jan 8, 2020 20:15:05 GMT
Curaleaf Completes Acquisition of Acres in Nevada
PR Newswire January 3, 2020
WAKEFIELD, Mass., Jan. 3, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced that it has closed on the acquisition of the retail assets of Acres Cannabis ("Acres"). The acquisition consists of Acres' award-winning flagship dispensary in the heart of Las Vegas, adjacent to the Strip, and another dispensary in Ely, Nevada. Curaleaf's operations in Nevada now include two cultivation facilities, two processing sites and two dispensaries located in Las Vegas, with the retail location in Ely expected to open in the second quarter of 2020.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 52 dispensaries, 14 cultivation sites and 14 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 52 dispensaries, 14 cultivation sites and 14 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.